At a glance
- Originator Novartis
- Class Analgesics; Antipyretics; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 08 Oct 2001 No-Development-Reported for Pain in Switzerland (Unknown route)
- 08 Oct 2001 No-Development-Reported for Pain in United Kingdom (Unknown route)